JAMA Network cover image

JAMA Internal Medicine : Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections

JAMA Network

00:00

Exploring the Potential of Azelastine Nasal Spray Against COVID-19

This chapter reviews the results of a phase two study on the efficacy of azelastine nasal spray in preventing SARS-CoV-2 infections, indicating its potential as an antiviral treatment. It highlights the necessity for additional research, especially a phase three trial to assess its impact on at-risk populations and examines the implications of its mechanism of action.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app